Mesoporous silica nanoparticles in medicine--recent advances.
about
Aerosol droplet delivery of mesoporous silica nanoparticles: a strategy for respiratory-based therapeuticsDesigning Dendrimer and Miktoarm Polymer Based Multi-Tasking Nanocarriers for Efficient Medical TherapyIn vitro toxicity evaluation of engineered cadmium-coated silica nanoparticles on human pulmonary cellsBiopolymer implants enhance the efficacy of adoptive T-cell therapy.Acidic pH-targeted chitosan capped mesoporous silica coated gold nanorods facilitate detection of pancreatic tumors via multispectral optoacoustic tomographyStimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer.Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles.Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.Kinetics of silica nanoparticles in the human placenta.Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry.Utilisation of nanoparticle technology in cancer chemoresistance.The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration.Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase InhibitorsHow nanotechnology can enhance docetaxel therapy.Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.Sustained Delivery Growth Factors with Polyethyleneimine-Modified Nanoparticles Promote Embryonic Stem Cells Differentiation and Liver Regeneration.Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies.MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery.Nanodrug delivery in reversing multidrug resistance in cancer cells.Dendritic silica particles with center-radial pore channels: promising platforms for catalysis and biomedical applications.Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents.Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.Nanocomposite-Based Photodynamic Therapy Strategies for Deep Tumor Treatment.Analyses in zebrafish embryos reveal that nanotoxicity profiles are dependent on surface-functionalization controlled penetrance of biological membranes.In-vitro cytotoxicity and cellular uptake studies of luminescent functionalized core-shell nanospheres.Mesoporous silica nanoparticles in tissue engineering--a perspective.Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.Recent advances in light-responsive on-demand drug-delivery systems.Delivery of Gemcitabine Prodrugs Employing Mesoporous Silica Nanoparticles.Highly efficient siRNA delivery from core-shell mesoporous silica nanoparticles with multifunctional polymer caps.
P2860
Q26343130-47203E1E-9CCE-4A10-9EA5-727D40E23DFDQ26782404-89387B58-2BD1-440A-864E-2E1DD9AA8D20Q28390141-7D56140A-15C2-49C2-9F75-78F1E5DD2BD2Q30614247-3F02813F-E52E-4094-A32E-A4BF1A2BA612Q30855722-BC148A9E-37AA-4718-ADB9-46DE774F9C62Q33635355-2F2BD091-5F64-4307-844A-6A9279A846D2Q34674541-B8928E25-64F6-4F06-8AFC-2686370F903DQ34881011-1C9D7ED5-8042-48D3-A7E3-88FD690BD1BEQ35099618-A6506BAA-EBC8-49AB-B05C-ED2400752967Q35174216-7659B0FE-ECFE-457F-8C1A-4A339F8CDBD3Q35270450-9E7BDF5E-32C0-48B1-8BA3-40F11DF60F6CQ35602386-DDD0925E-3AFC-4278-B0F9-579D6416C871Q35984023-9353EF14-FB0F-4540-ACB6-38ED1D3945A4Q36263478-391BAC33-4F99-4B42-AB10-597318A03D74Q36402145-ABC64A71-E0A1-4399-9DFA-82ABF5F0793DQ36421258-8436956D-76FA-4E96-94F7-C3686DA1CBAEQ36581781-D4573F81-07A1-43B1-9AC0-12D0BAE40100Q36939783-A4018421-9F69-4C03-90E8-48225679B8B2Q37091683-D1FAE946-358E-43D5-9BAD-049B9D04FBA5Q37134529-D07DCE35-FECF-4ADA-B7AB-21127E4EA3E5Q37352321-C59840A2-8EE7-4B9A-B3EE-F201EA177808Q37404653-F07466FE-3953-4CA7-AF78-9AAE50125356Q38154210-431E2846-A5CD-42BB-B6C3-820997F8920AQ38205561-B6A12701-1C95-41BF-9C66-FDEDC376BC6AQ38215663-FCE1C267-FC57-49A7-AB87-6E0CD6FFD06EQ38217698-CF920042-E35B-4D19-A05C-8A8C0205B6A4Q38234908-89FBEF63-0E22-4E40-8150-60273B29CD80Q38264779-C9355FF3-2FA1-4039-B2E5-817DF0D8758FQ38269215-EE3B1DCF-32C9-4A48-A035-6FB7D0425A24Q38494691-B7A22EDC-F26A-415E-A755-373ADB696951Q38591548-6A8785E4-419A-48B9-B86E-5A19C149C11BQ38615276-4566D004-4CC3-4840-B583-D3FB111DB9D6Q38693760-53F8B786-BC8F-4169-AB18-10BAFFD5CC5EQ38702716-EB64B9F8-535D-4C65-B861-CFF9D032E74DQ38712927-9309D4B3-33C3-4C69-BB77-E47DF145B8D0Q38717731-5E4D5618-37F3-488F-A1FD-0A76EE373FFDQ38758605-903AF34B-BCFB-49E4-B592-A598AF00D869Q38770340-4A8B8891-73C0-4363-953A-BE7AF103A5DFQ38775652-855C8973-FA64-4F02-B0A7-336ACA136814Q38799002-13931F90-8721-4762-905E-436D8DB9AE44
P2860
Mesoporous silica nanoparticles in medicine--recent advances.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mesoporous silica nanoparticles in medicine--recent advances.
@en
type
label
Mesoporous silica nanoparticles in medicine--recent advances.
@en
prefLabel
Mesoporous silica nanoparticles in medicine--recent advances.
@en
P2093
P1476
Mesoporous silica nanoparticles in medicine--recent advances.
@en
P2093
Cecilia Sahlgren
Mika Lindén
Veronika Mamaeva
P304
P356
10.1016/J.ADDR.2012.07.018
P407
P577
2012-08-18T00:00:00Z